CAS 31542-63-9
:1,3-Dipropil-7-metilxantina
- 1,3-Dipropylheteroxanthine
- 1H-Purine-2,6-dione, 3,7-dihydro-7-methyl-1,3-dipropyl-
- 3,7-Dihydro-7-methyl-1,3-dipropyl-1H-purine-2,6-dione
- 7-Methyl-1,3-dipropylxanthine
- 7-methyl-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione
- Heteroxanthine, 1,3-dipropyl-
- Sc 5192
- (1,3)-Dipropyl-7-methylxanthine
7-Methyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione
CAS:Fórmula:C12H18N4O2Forma y color:SolidPeso molecular:250.29691,3-Dipropyl-7-methylxanthine
CAS:Producto controladoApplications A phosphodiesterase inhibitor and caffeine analog with some selectivity for A2 adenosine receptors. UV lmax = 273 nm, log e=3.98.
References Clark, K., et al.: J. Physiol., 481, 129 (1994), Liu, W., et al.: Pharmacol., 54, 135 (1997), Zarrindast, M., et al.: Eur. Neuropsychopharmacol., 13, 165 (2003), Malki, A., et al.: Exp. Oncol., 28, 16 (2006),Fórmula:C12H18N4O2Forma y color:NeatPeso molecular:250.301,3-Dipropyl-7-methylxanthine
CAS:Producto controlado1,3-Dipropyl-7-methylxanthine is a xanthine compound that is structurally related to caffeine. It has been shown to have an inhibitory effect on the production of reactive oxygen species and cytosolic calcium levels in primary cells, as well as a nonselective adenosine receptor antagonist activity. It has also been shown to antagonize the effects of adenosine receptors, p2 receptors, and p2y receptors. This drug is used for the treatment of basophilic leukemia.
Fórmula:C12H18N4O2Pureza:Min. 95%Peso molecular:250.3 g/molRef: 3D-FD22522
Producto descatalogado



